Abstract
INTRODUCTION
Alopecia areata involves a chronic inflammation that impacts on hair follicles and results in hair loss, and its etiology is associated with genetics, autoimmunity, and environmental factors [1] . Recent studies show that there is a close link between alopecia areata and gut dysbiosis [2, 3] . In recent years, fecal microbiota transplantation (FMT), a strategy to treat gut dysbiosis through restoring a healthy gut microbiome, has been strongly recommended to treat Clostridium difficile (previously known as Clostridioides difficile) infection (CDI) in clinical practice [4] , and it has also been employed to treat patients with other gut dysbiosis-related diseases, such as inflammatory bowel disease (IBD, including ulcerative colitis and Crohn's disease), irritable bowel syndrome (IBS), liver disease, and constipation [5] [6] [7] [8] [9] . Here we present a case of alopecia areata in whom hair regrew following FMT.
CASE PRESENTATION

Chief complaints
On April 5, 2017, an 86-year-old man, suffering from recurrent abdominal pain and distension, and diarrhea, was seen at the Outpatient Department of Gastroenterology, the First Affiliated Hospital of Guangdong Pharmaceutical University.
History of present illness
The patient's symptoms had sustained for six months, with inappetence. His stool frequency was 4-5 times per day, without fever or bloody purulent stool. At admission, he was also diagnosed with depression and treated with Deanxit (flupentixol and melitracen) tablets. respiratory rate was 20 breaths per minute, blood pressure was 123/72 mmHg, and body mass index (BMI) was 17.2 kg/m 2 . Upon physical examination, the patient presented with a 1.5 cm × 2.0 cm alopecia areata on his right occiput (no photo was taken). The abdomen was soft with no tenderness or rebound tenderness.
Laboratory examinations
Serum albumin was decreased at 35 g/L (normal range 40-55 g/L). Blood routine examination, stool routine examination, and fecal occult blood test were all negative.
Imaging examinations
The normal mucosae of the stomach and small intestine were observed on capsule endoscopy. Colonoscopy was conducted, which showed that the mucosa of the colon appeared to be normal (Figure 1 ).
FINAL DIAGNOSIS
According to the above examinations, we excluded infectious diarrhea on the basis of the negative results of laboratory testing, capsule endoscopy, and colonoscopy. The patient was diagnosed with noninfectious diarrhea, depressive disorder, and patchy alopecia areata.
TREATMENT
Due to the negative results of laboratory testing, capsule endoscopy, and colonoscopy, and no usage of antibiotic, we considered that noninfectious diarrhea in the elderly patient was mainly caused by gut dysbiosis [10] [11] [12] , but not by diseases (including pancreatic exocrine insufficiency, bile acid malabsorption, gastrointestinal tumor, and Crohn's disease) and antibiotic-associated colitis. Thus, the patient was given six rounds of FMT for noninfectious diarrhea on April 10, April 12, April 14, May 17, May 19, and May 22, 2017, respectively. The stool for FMT was obtained from a 22-year-old healthy male donor, in whom we conducted the routine screening for potential pathogens according to the selection criteria formulated by Zhang's group [13, 14] . The fresh fecal microbiota suspension, prepared with the automatic purification system (GenFMTer; FMT Medical, Nanjing, China), was administered through the lower digestive tract with a colonoscope, following the laboratory protocol formulated by Zhang's group [13] .
OUTCOME AND FOLLOW-UP
During the 18-mo follow-up after six rounds of FMT, with the last follow-up visit on November 22, 2018, his stool frequency was reduced to 1-2 times per day, with the improved appetite and no abdominal pain or distension. Specifically, his diarrhea improved remarkably one month after FMT. His depressive symptoms were also improved; his score on the Hamilton Depression Scale (HAM-D 17 ) [15] was reduced from 30 points at administration to 13 points at the last visit. His BMI rose to 18.3 kg/m 2 , and serum albumin increased slightly to 38 g/L. Surprisingly, at the follow-up 4 wk after FMT, he reported new hair growth on the affected region of his scalp, with some of his white hair gradually turning to black, without taking any other therapies for alopecia areata before and after FMT. His hair growth maintained at the last visit ( Figure 2 ). In addition, the senile plaques on his face disappeared at the same time (no photo was taken).
DISCUSSION
We present the case of an elderly Chinese patient who experienced new hair growth on the alopecia areata-affected regions of his scalp, with restoration of hair pigmentation, after receiving FMT, which was indicated for noninfectious diarrhea. Furthermore, his diarrhea and depressive symptoms improved and the senile plaques on his face disappeared at the same time. We speculate that all of these changes are related to altered gut microbiota after FMT.
Gut dysbiosis plays a critical role in infectious diarrhea [16, 17] . FMT has been performed to treat Clostridium difficile-associated diarrhea, which was more effective than vancomycin or placebo treatment [18] . Beyond infectious diarrhea, gut dysbiosis also plays an important role in noninfectious diarrhea [10] [11] [12] . A double-blind, randomized, placebo-controlled, parallel-group, single-center trial revealed that symptoms of IBS, including diarrhea, got improved significantly after receiving FMT [7] . In our FMT trial center at the First Affiliated Hospital of Guangdong Pharmaceutical University, we have treated about 40 patients with diarrhea using FMT, showing significant symptom improvement (data not published). In this case, we conducted FMT in the elderly patient for his noninfectious diarrhea. During the treatment, we observed hair regrowth on the alopecia areata-affected regions of his scalp surprisingly.
Clinical patterns of alopecia areata comprise patchy alopecia areata, alopecia totalis, and alopecia universalis [19] . The following factors contribute to the pathogenesis of alopecia areata: (1) Genetics: 62 genes have been identified to be involved in the pathogenesis of alopecia areata [19] ; (2) Immune response: The loss of the immune privilege with the subsequent attack of autoreactive infiltrates on the hair follicle is considered to be the predominant cause of alopecia areata [1, 19, 20] ; and (3) Other factors: Oxidative stress and infectious agents could lead to breakdown of the immune privilege and initiation of alopecia areata [19, 20] . In addition, psychological stress may act as an aggravating factor in initiation and progression of alopecia areata, although this is controversial [20] [21] [22] [23] . Several treatments do result in hair growth in patients with alopecia areata. First, application of local corticosteroids shows a positive curative effect in patchy alopecia areata. But this treatment cannot inhibit the development of alopecia areata at other sites [1, 19] . Second, patients with extensive and rapidly progressive alopecia areata got benefits from application of systemic corticosteroids [19, 24, 25] . However, continued application is required to maintain hair growth in most cases [19] . Third, contact immunotherapy is effective for patients with patchy alopecia areata, not for those with alopecia totalis and alopecia universalis [19] . But a high relapse rate (62%) of this management becomes a disturbing issue [19] . Therefore, none of the treatments mentioned above has been ratified by the US FDA, indicating that a new and more effective therapeutic intervention aiming at new targets is needed.
Recently, several studies demonstrated that gut dysbiosis plays critical roles in the onset of skin diseases, including atopic dermatitis and psoriasis [26] [27] [28] [29] . However, the association between alopecia areata and gut dysbiosis awaits to be elucidated. Alopecia areata may link with other autoimmune diseases, especially with IBD [30] . A series of clinical cases reported that hair loss was found in patients with IBD [31] [32] [33] [34] , with little knowledge of its causes. Since gut dysbiosis is one of the major pathogenesis of IBD [35] [36] [37] , gut dysbiosis may act as a common pathway coexisting with alopecia areata and IBD. Biotin (vitamin B7), a water-soluble vitamin, has the heavy reliance on bacterial production in guts. Hair loss is one of the symptoms of biotin deficiency [38] , which is induced by a variety of factors, including IBD [39] . Lately recently, Hayashi et al [2] reported that alopecia was developed in biotin-deficient germ-free mice, with overgrowth of Lactobacillus murinus. The alopecia mice showed hair regrowth after supplementation of biotin, with reduction of Lactobacillus murinus, indicating that alopecia was caused mainly by gut dysbiosis, particularly overgrowth of Lactobacillus murinus, which consequently led to biotin deficiency [2] . Thus, it is not implausible that there exists a close link between gut dysbiosis and alopecia areata.
Short-chain fatty acids (SCFAs), produced by gut microbiota, contribute to maintaining immunological homeostasis [40] , via modulating the numbers and function of regulatory T cells (Tregs), which play critical role in the induction of alopecia areata [3, 30] . Borde et al [3] hypothesized that propionate, one of SCFAs, would induce more tolerogenic Tregs through stimulating G protein-coupled receptors to protect the hair follicles against the immunological attack. They observed that hair regrowth in five out of five C3H/He J mice (a kind of mouse developing alopecia areata spontaneously) after 11 wk of propionate treatment, with an increased Treg/CD4 + ratio. Unfortunately, they failed to reproduce the positive results of hair regrowth when they repeated the study. Due to the vast varieties of gut microbiota, it is insufficient to restore the normal gut microbiota merely through supplying one of SCFAs, which leads to the inconclusive results. Nevertheless, the intriguing link between gut dysbiosis and alopecia areata does exist, and restoring a healthy gut, instead of supplying one to several kinds of SCFAs, will perform more effectively in treating alopecia areata.
Vitamin D, one of the micronutrients in our daily diet, is well-known for the effect of maintaining the normal levels of calcium and phosphorus in the blood [41] . Vitamin D exerts its biological functions through conversion into its active form of 1,25(OH) 2 D 3 by the activating enzyme Cyp27B1 [42] . 1,25(OH) 2 D 3 binds to vitamin D receptor (VDR) to possess biological activities [43] . Growing evidence demonstrates that 1,25 (OH) 2 D 3 deficiency is associated with alopecia areata [44] [45] [46] , in which VDR deficiency plays a vital role [47] [48] [49] . On one hand, a recent study indicated that 1,25(OH) 2 D 3 deficiency induced gut dysbiosis, leading to a reduction in SCFAs production [50] . On the other hand, several studies have shown that the expression of VDR and Cyp27B1 is regulated by gut microbiota [51] [52] [53] . Thus, it is unclear which takes the main responsibility for the onset of alopecia areata, although it is likely that there exists a bidirectional relationship between 1,25(OH) 2 D 3 and gut microbiota and between 1,25(OH) 2 D 3 deficiency and gut dysbiosis [43] . FMT is considered a safe and effective method to restore a healthy gut microbial environment, and displays astonishing clinical efficacy for recurrent CDI, IBD, IBS, liver disease, and other disorders [54] [55] [56] [57] . The rationale for FMT restoring health is still unclear. Ooijevaar et al [58] proposed that there could be two pathways, the direct and indirect pathways. In the direct pathway, some beneficial bacteria and nutrients are transferred directly with FMT to compete with the pathogenic bacteria and replenish the missing nutrients, the process of which is unrelated to the host. In the indirect pathway, host-related factors, including immunomodulation and mechanical barrier function, are involved.
This widespread efficacy of FMT provides a clue that FMT might also serve as a potential therapy for alopecia areata via the restoration of gut microbiota balance [3, 30] . In 2017, Rebello et al [59] reported that two patients with alopecia universalis experienced hair regrowth after FMT used for recurrent CDI. Consistent with these two cases, the elderly patient with patchy alopecia areata in this case demonstrated long-term hair growth after FMT for noninfectious diarrhea (Table 1 ). These observations suggest that FMT contributes to hair regrowth by replenishing the gut microbiota. Restoration of a healthy gut microbial environment might lead to improvement of the absorption and synthesis of nutrients, including amino acid/proteins, biotin, SCFAs, and vitamin D, by immunomodulation, which ultimately results in hair regrowth. In this case, the elderly patient got his nutritional status improved after FMT, as his BMI and serum albumin increased slightly. Unfortunately, we could not provide the levels of biotin and vitamin D of this patient before and after FMT; acquisition of this information might help to elucidate the mechanism by which FMT results in hair regrowth. In addition to hair regrowth, the elderly patient we report here reported that his hair color returned and the senile plaques on his face disappeared. The pathogenesis of canities has not been completely understood yet. Certain organ-specific autoimmune disorders may contribute to the process of canities [60] , which gives us a hint that the gut microbiota may be associated with the process of canities. Hence, our elderly patient could get his hair color returned after restoration of the balance of the gut microbial environment.
As the gut microbiota acts as a direct mediator of psychopathology through the gut-brain axis [61, 62] , the patient's depressive symptoms were also improved after FMT.
CONCLUSION
In conclusion, despite the astonishing therapeutic effect described in this report, as well as in the report by Rebello et al [59] , further investigations on the role of the gut microbiota in alopecia areata through large and well-designed clinical trials are required to support the clinical application of FMT as a treatment option for this distressing disease.
